Crispr Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.4M | 29k | 46.98 |
| 2024-06-30 | $5.4M | 100k | 54.01 |
| 2024-03-31 | $1.1M | 17k | 68.14 |
| 2023-12-31 | $983k | 16k | 62.61 |
| 2023-09-30 | $635k | 14k | 45.36 |
| 2023-06-30 | $786k | 14k | 56.14 |
| 2023-03-31 | $565k | 13k | 45.20 |
| 2022-12-31 | $508k | 13k | 40.64 |
| 2022-09-30 | $640k | 9.8k | 65.31 |
| 2022-06-30 | $596k | 9.8k | 60.82 |
| 2022-03-31 | $634k | 10k | 62.77 |
| 2021-12-31 | $765k | 10k | 75.74 |
| 2021-09-30 | $1.1M | 10k | 111.88 |
| 2021-06-30 | $1.7M | 10k | 161.86 |
| 2021-03-31 | $1.1M | 8.9k | 121.80 |
| 2020-12-31 | $1.4M | 8.9k | 153.15 |
| 2020-09-30 | $945k | 11k | 83.63 |
| 2020-06-30 | $441k | 6.0k | 73.50 |